Key facts
- This page summarizes Kurma Partners's Form 3 filing for IO Biotech, Inc. (IOBT).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2023, 15:40.
Kurma Partners - 09 Aug 2023 Form 3 Insider Report for IO Biotech, Inc. (IOBT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- IOBT
- Reported as of
- 09 Aug 2023
- Net transaction value
- $0
- Reporting owner signature
- Kurma Partners, by: /s/ Remi Droller, Managing Partner
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Kurma Partners filed Form 3 for IO Biotech, Inc. (IOBT) on 21 Aug 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IOBT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,345,679
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Footnotes
- F1, F4
IOBT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,852,026
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Footnotes
- F2, F4
IOBT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 623,428
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IOBT
holding
Derivative
Warrants (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 4,345,679
- Exercise price
- $2.47
- Footnotes
- F1, F4, F5
IOBT
holding
Derivative
Warrants (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 812,815
- Exercise price
- $2.47
- Footnotes
- F2, F4, F5
IOBT
holding
Derivative
Warrants (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 09 Aug 2023
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 273,603
- Exercise price
- $2.47
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The securities are held by Kurma Growth Opportunities Fund FPCI. Kurma Partners is the management company of Kurma Growth Opportunities Fund FPCI.
Footnote F2
The securities are held by Kurma Biofund III FPCI. Kurma Partners is the management company of Kurma Biofund III FPCI.
Footnote F3
The securities are held by SKCI FPCI. Kurma Partners is the management company of SKCI FPCI.
Footnote F4
The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
Footnote F5
These warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition (as such term is defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023).